Utility of N-terminal pro b-type natriuretic peptide (NT-PROBNP) dosage in differential diagnosis of acute dyspnoea

E. Battaglia, C. Bonfardeci, S. Bordoni, S. Amaducci (Milan, Italy)

Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Session: Comorbidities and case management in primary respiratory care
Session type: E-Communication Session
Number: 451
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Battaglia, C. Bonfardeci, S. Bordoni, S. Amaducci (Milan, Italy). Utility of N-terminal pro b-type natriuretic peptide (NT-PROBNP) dosage in differential diagnosis of acute dyspnoea. Eur Respir J 2009; 34: Suppl. 53, 451

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The use of plasma n-terminal pro B-type natriuretic peptide (proBNP) concentrations in differential diagnosis of comorbidity pulmonary patients
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011


Comparison of brain natriuretic peptide to n-terminal pro brain natriuretic peptide in idiopathic interstitial pneumonia
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009


Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure.
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020


The role of N-terminal pro B-type natriuretic peptide in predicting mortality of community acquired pneumonia
Source: International Congress 2019 – Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis
Year: 2019




Diagnostic value of N-terminal pro-brain natriuretic peptide levels in pleural effusions of cardiac origin
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010


Brain natriuretic peptide (BNP) levels during acute exacerbations of COPD – a novel biomarker
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008


Brain natriuretic peptide (BNP) determination in patients hospitalized for COPD exacerbation
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008


Correlation of levels of N-terminal pro-B-type natriuretic peptide with localization of thrombus in acute pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011

N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patient with acute exacerbations (AE) of COPD
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008


The prognostic value of repeated measurements of N-terminal pro-B-type natriuretic peptide in patients with pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010


B-type natriuretic peptide (BNP) in COPD patients with acute respiratory failure (ARF)
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010

Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism
Source: Eur Respir J 2014; 43: 1669-1677
Year: 2014




New evidence of the effect of B-type natriuretic peptide (BNP) on human bronchi
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD
Year: 2008

Plasma n-terminal pro-brain natriuretic peptide (NT pro-BNP) level in respiratory diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 583s
Year: 2003

Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia
Source: Eur Respir J 2007; 30: Suppl. 51, 481s
Year: 2007

Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004

Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH
Source: ERJ Open Res, 6 (4) 00356-2020; 10.1183/23120541.00356-2020
Year: 2020



Prognostic significance of amino-terminal pro-brain natriuretic peptide testing among waitlisted lung transplant candidates
Source: Virtual Congress 2021 – Challenging problems in lung transplantation
Year: 2021

N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism
Source: Eur Respir J 2003 Oct 01;22(4):649-653
Year: 2003



Prognostic value of serum N-terminal brain natriuretic peptide type B for pulmonary hypertension among patients with usual interstitial pneumonia and sarcoidosis
Source: Annual Congress 2007 - Pulmonary vascular involvement in smoking and respiratory diseases
Year: 2007